Status:
COMPLETED
Botulinum Neurotoxin Type A (BoNT-A) in Paediatric Non-neurogenic Therapy Resistant Overactive Bladder (OAB)
Lead Sponsor:
University of Aarhus
Conditions:
Overactive Bladder
Incontinence, Daytime Urinary
Eligibility:
All Genders
6-17 years
Brief Summary
A non-intervention cohort study on the use of Botulinum Neurotoxin Type A (BoNT-A) in Paediatric Non-neurogenic Therapy Resistant Overactive Bladder (OAB). Primary endpoint was the reduction of urinar...
Detailed Description
The investigators wanted to cunduct an analysis of children with urinary incontinence who received intradetrusor injection of BoNT-A in the period 01.01.2016 to 31.12.2020 at their centre. All patient...
Eligibility Criteria
Inclusion
- OAB
- Intradetrusor BoNT-A
Exclusion
- Neurogenic OAB
Key Trial Info
Start Date :
January 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 15 2022
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT06569342
Start Date
January 15 2022
End Date
June 15 2022
Last Update
August 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospiral
Aarhus, Region Midt, Denmark, 8200